FS222 First in Human Study in Patients With Advanced Malignancies

Clinical trial NCT04740424 · RECRUITING

Trial details

NCT number: NCT04740424
Sponsor: invoX Pharma Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Metastatic Cancer

Start date: 2020-12-14
Primary completion: 2027-10-30
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.